TASC commercial portfolio
Tayside has continued commitment to delivery and performance in an environment where the study mix is becoming more challenging and labour-intensive.
On this page
Studies in Tayside
Tayside has taken part in 166 commercial research studies in the past 5 years (2018-2022)
Our Tayside studies were in the following categories:
- 75% drug trials
- 8% questionnaire studies
- 5% limited to data
- 4% medical device trials
- 8% Other studies
Active therapy areas
Our most active therapy areas are:
- Cancer 23%
- Cardiovascular 14%
- Respiratory 13%
- Neuroprogressive and Dementia 11%
- Diabetes 9%
- Dermatology 7%
- Children, 6%
- Other 17%
Study recruitment
During this 5 year period we recruited 1104 participants to commercial trials in Tayside.
30 of our studies recruited to target, a further 31 over recruited and 37 studies recruited between 50% and100% of target. (2018-2022)
